Repetition of the passed or new opportunities? Comments on Duntas L. New aspects of an old dilemma: treatment of hypothyroidism with L-thyroxine combined with L-triiodothyronine
https://doi.org/10.14341/ket2017311-13
Abstract
This article is for comments and comprehensive discussion on relatively published review “New aspects of an old dilemma: treatment of hypothyroidism with L-thyroxine combined with L-triiodothyronine” by L. Duntas.
About the Author
Galina A. Melnichenko
https://www.endocrincentr.ru/rukovodstvo/melnichenko-galina-afanasevna
Russian Federation
Endocrinology Research Centre
Russian Federation
MD, PhD, Professor
References
1. Болезни щитовидной железы. / Под ред. Бравермана Л.И. — М.: Медицина; 2000. [Braverman LI, editor. Bolezni shchitovidnoy zhelezy. Moscow: Meditsina; 2000. (In Russ.)]
2. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ, Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424-429. doi: 10.1056/NEJM199902113400603
3. Fadeyev VV, Morgunova TB, Melnichenko GA, Dedov II. Combined therapy with L-Thyroxine and L-Triiodothyronine compared to L-Thyroxine alone in the treatment of primary hypothyroidism. Hormones. 2010;9(3):245-252. doi: 10.14310/horm.2002.1274
4. Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J. 2012;1(2):55-71. doi: 10.1159/000339444
5. Wiersinga WM. Therapy of endocrine disease: T4 + T3 combination therapy: is there a true effect? Eur J Endocrinol. 2017;177(6):R287-R296. doi: 10.1530/EJE-17-0645
Review
For citations:
Melnichenko G.A. Repetition of the passed or new opportunities? Comments on Duntas L. New aspects of an old dilemma: treatment of hypothyroidism with L-thyroxine combined with L-triiodothyronine. Clinical and experimental thyroidology. 2017;13(3):11-13. (In Russ.) https://doi.org/10.14341/ket2017311-13
Views:
7101
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
